Delivery Order SPE2DB20D3303-SPE2DB24FZ8F4
Award Date
5/24/24
Potential Completion Date
5/28/24
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products to the Defense Logistics Agency (DLA). The $11,757.06 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $10,056.16 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 2, 2024 with a completion date of August 5, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products to the Defense Logistics Agency (DLA). The $5,379.80 firm fixed price delivery order was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a period of performance through May 31, 2024 and is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,108.61 firm fixed-price contract is for the supply of DUPIXENT 200 MG/1.14 ML PEN 1.14ML, a specialized pharmaceutical product, with a period of performance through November 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense-focused agency within the Department of Defense (DoD). The $17,398.28 delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical and medical...
This federal contract award is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a prescription pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies globally. The contract is a delivery order valued at $19,455.58 with a firm fixed price pricing type. It does not have a set-aside designation. Amerisourcebergen holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,222.59 firm fixed-price delivery order is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product. The contract has an ultimate completion date of August 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,652.35 firm fixed-price contract is for the supply of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. This order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a $5,613.53 firm fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of DUPIXENT 200 MG/1.14 ML PEN 1.14ML pharmaceutical products. This order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical supplies to DLA facilities...
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $21,113.59. This is a firm fixed-price delivery order contract with a completion date of February 9, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00...